University of Iowa Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title

Heart Sensor Study


Champion: CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients 

HF Pressure Measurement System

A pressure sensor is intended to be implanted into the pulmonary artery at the time of Swan-Ganz catheterization.

The primary hypothesis is that the TREATMENT group will have a significantly lower rate of HF-related hospitalizations than the CONTROL group. ( Time Frame: 6 months). This trial is closed to enrollment and is follow-up phase.

This trial is closed to enrollment and continues in follow up phase.

Start Date
September 1, 2007
End Date
September 26, 2014
Gender Preference
Age Group
18 - 99 years
Principal Investigator
Frances Johnson, MD
Contact Info

Cardiomyopathy Treatment Program

Cynthia Larew RN  319-356-1028 pager # 2123

Department or Field of Study
cardiomyopathy ; device for treatment of heart failure ; Heart ; heart failure ; pulmonary artery pressure sensor ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.